Lung tumor immune evasion mechanism in Non-small cell lung cancer (NSCLC) targets pSTAT5 in CD4+CD25+FoxP3-T effector cells

Tausche P, Trufa D, Geppert CI, Rieker R, Sirbu H, Neurath-Finotto S (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Journal of Immunology American Association of Immunologists

Publisher: AMER ASSOC IMMUNOLOGISTS

City/Town: BETHESDA

Conference Proceedings Title: JOURNAL OF IMMUNOLOGY

DOI: 10.4049/jimmunol.206.supp.56.07

Authors with CRIS profile

Patrick Tausche Lehrstuhl für Genetik Denis Trufa Department of Thoracic Surgery Carol-Immanuel Geppert Institute of Pathology Ralf Rieker Institute of Pathology Horia Sirbu Professur für Thoraxchirurgie Susetta Neurath-Finotto Professur für Molekulare Pneumologie

How to cite

APA:

Tausche, P., Trufa, D., Geppert, C.-I., Rieker, R., Sirbu, H., & Neurath-Finotto, S. (2021). Lung tumor immune evasion mechanism in Non-small cell lung cancer (NSCLC) targets pSTAT5 in CD4+CD25+FoxP3-T effector cells. In JOURNAL OF IMMUNOLOGY. BETHESDA: AMER ASSOC IMMUNOLOGISTS.

MLA:

Tausche, Patrick, et al. "Lung tumor immune evasion mechanism in Non-small cell lung cancer (NSCLC) targets pSTAT5 in CD4+CD25+FoxP3-T effector cells." Proceedings of the JOURNAL OF IMMUNOLOGY BETHESDA: AMER ASSOC IMMUNOLOGISTS, 2021.

BibTeX: Download